An open-label, single-dose, randomized, 2-period, crossover, bioequivalence study to compare levonorgestrel 90 mg/ethinyl estradiol 20 mg in 2 dosage forms with different dissolution characteristics in healthy, cycling women
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 23 Aug 2010
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary)
- Indications Pregnancy
- Focus Pharmacokinetics
- Sponsors Wyeth
- 21 Jul 2009 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 05 May 2007 New trial record.